Standout Papers
Citation Impact
Citing Papers
ASPM Is a Novel Marker for Vascular Invasion, Early Recurrence, and Poor Prognosis of Hepatocellular Carcinoma
2008
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
2016
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2011
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The Metabolic Syndrome and Inflammation
2004
Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women
2003
Thiazolidinediones
2004 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Pioglitazone and cardiovascular risk. A comprehensive meta‐analysis of randomized clinical trials
2008
Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment
2013
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies
2009
Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog
2012
Obesity, inflammation, and liver cancer
2011
Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors
2004
ACRP30, a new hormone controlling fat and glucose metabolism
2002
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy†,‡
2010
Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C
2013
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up
2016
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease
2004
The metabolic syndrome
2010 Standout
Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies
2012
Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma
2017
Adipokines: molecular links between obesity and atheroslcerosis
2005
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
2004 Standout
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients
2002
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
The role of quantitative hepatitis B surface antigen revisited
2016
Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
2015
Effect of Lifestyle Modification on Adipokine Levels in Obese Subjects with Insulin Resistance
2003
Hydroxylation and Glycosylation of the Four Conserved Lysine Residues in the Collagenous Domain of Adiponectin
2002 Standout
Protein tyrosine phosphatases: from genes, to function, to disease
2006
Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin
2002
Differential Regulation of Adiponectin Secretion from Cultured Human Omental and Subcutaneous Adipocytes: Effects of Insulin and Rosiglitazone
2002
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Adiponectin: Systemic contributor to insulin sensitivity
2003
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Testosterone Selectively Reduces the High Molecular Weight Form of Adiponectin by Inhibiting Its Secretion from Adipocytes
2005
Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors
2014
The metabolic syndrome
2005 Standout
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
2010
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin
2003
Pro12Ala substitution in peroxisome proliferator-activated receptorγ2 is associated with low adiponectin concentrations in young Japanese men
2004
Revealing the human mucinome
2022 StandoutNobel
Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk
2015
IgE, Mast Cells, and Eosinophils in Atopic Dermatitis
2011
Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls
2004
Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status
2013
Chronic hepatitis B: Update 2009 #
2009 Standout
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study
2017
Plasma Adiponectin Levels in Overweight and Obese Asians
2002
Hypoxic gene expression and metastasis
2004
Polycystic Ovary Syndrome
2005 Standout
Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ Agonists
2005
Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report
2011
Animal models of nonalcoholic fatty liver disease
2010
The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones
2003
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
What We Talk About When We Talk About Fat
2014 Standout
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Identification of Osteopontin as a Novel Marker for Early Hepatocellular Carcinoma
2011
Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
2014
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Decreased Plasma Adiponectin Levels in Young Obese Males.
2003
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection
2015
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Common polymorphisms in the PPARγ2 and IRS-1 genes and their interaction influence serum adiponectin concentration in young Finnish men
2005
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
2015
Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants
2017
Critical analysis of literature on low-dose synergy for use in screening chemical mixtures for risk assessment
2011
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Hepatocellular carcinoma
2022 Standout
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
2003 Standout
Hepatocellular carcinoma: a global view
2010
Hypoadiponectinemia Is Associated with Insulin Resistance, Hypertriglyceridemia, and Fat Redistribution in Human Immunodeficiency Virus-Infected Patients Treated with Highly Active Antiretroviral Therapy
2003
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
2008
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
2015
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Hepatocellular Carcinoma
2019 Standout
Life with Oxygen
2007 StandoutScienceNobel
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy
2015
Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients
2004
AASLD guidelines for treatment of chronic hepatitis B
2015
Surveillance for Hepatocellular Carcinoma in Patients with NASH
2016
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Adiponectin as a Biomarker of the Metabolic Syndrome
2004
Adiponectin Expression From Human Adipose Tissue
2003
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
2003
The Broad Scope of Health Effects from Chronic Arsenic Exposure: Update on a Worldwide Public Health Problem
2013 Standout
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Association of the T-G Polymorphism in Adiponectin (Exon 2) With Obesity and Insulin Sensitivity
2002
Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension
2003
Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
2016
Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice
2008 StandoutNobel
Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure
2005
Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification
2005
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
2003
Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy
2003
Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B
2016
Adiponectin: a key adipocytokine in metabolic syndrome
2006
The Effect of Thiazolidinediones on Plasma Adiponectin Levels in Normal, Obese, and Type 2 Diabetic Subjects
2002
Regulate to reduce chemical mixture risk
2018 StandoutScience
The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism
2002
Human Macrophages Promote the Motility and Invasiveness of Osteopontin-Knockdown Tumor Cells
2007
Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome
2005
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Adiponectin: More Than Just Another Fat Cell Hormone?
2003
Mutations in mouse Aspm (abnormal spindle-like microcephaly associated) cause not only microcephaly but also major defects in the germline
2010 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Adiponectinemia in Visceral Obesity: Impact on Glucose Tolerance and Plasma Lipoprotein and Lipid Levels in Men
2005
Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch
2018 StandoutNobel
Adiponectin, an Adipocyte-Derived Protein, Predicts Future Insulin Resistance: Two-Year Follow-Up Study in Japanese Population
2004
Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
2011
Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta‐analysis
2017
Sexual Differentiation, Pregnancy, Calorie Restriction, and Aging Affect the Adipocyte-Specific Secretory Protein Adiponectin
2003
Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
2003 StandoutScience
A Haplotype at the Adiponectin Locus Is Associated With Obesity and Other Features of the Insulin Resistance Syndrome
2002
Works of Chi‐Ling Chen being referenced
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
2014
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
2008
Long-Term Outcomes After Resection Versus Transplantation for Hepatocellular Carcinoma Within UCSF Criteria
2011
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma
2003
Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads
2012
Correlation between age and allergens in pediatric atopic dermatitis
2004
Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter
2005
Association of Lipid Profiles With Hepatitis C Viral Load in Chronic Hepatitis C Patients With Genotype 1 or 2 Infection
2009
Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan
2021
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
2012
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
2008
Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan
2009
Risk Stratification of Hepatocellular Carcinoma in Hepatitis B Virus e Antigen–Negative Carriers by Combining Viral Biomarkers
2013
Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters
2011
Ingested Arsenic, Cigarette Smoking, and Lung Cancer Risk
2004
Determinants of Spontaneous Surface Antigen Loss in Hepatitis B E Antigen–Negative Patients With A Low Viral Load
2011
Serum Hepatitis B Virus-DNA Levels Correlate With Long-term Adverse Outcomes in Spontaneous Hepatitis B e Antigen Seroconverters
2011
Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly
2007
Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
2013
Interferon α‐2b with and without ribavirin in the treatment of hepatitis B e antigen–positive chronic hepatitis B
2006
Plasma Adiponectin Levels and Blood Pressures in Nondiabetic Adolescent Females
2003
One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature
2017
Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin
2001 Standout
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters
2014
Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
2006
Hormone Replacement Therapy in Relation to Breast Cancer
2002
Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B
2018
Association of Lipid Profiles With Hepatitis C Viral Load in Chronic Hepatitis C Patients With Genotype 1 or 2 Infection
2009
Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients
2002